Aurinia Pharmaceuticals Inc.
AUPH
$15.36
$0.181.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 314.11M | 298.21M | 287.20M | 77.84M | 60.64M |
| Total Depreciation and Amortization | 19.38M | 19.41M | 19.45M | 19.45M | 19.48M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -157.32M | -154.03M | -162.21M | 15.62M | 20.75M |
| Change in Net Operating Assets | -932.00K | 3.32M | -8.78M | 7.20M | -8.17M |
| Cash from Operations | 175.24M | 166.92M | 135.66M | 120.10M | 92.68M |
| Capital Expenditure | -176.00K | -274.00K | -252.00K | -461.00K | -256.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 5.21M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.81M | -81.61M | -32.52M | 43.67M | 46.67M |
| Cash from Investing | 12.84M | -81.88M | -32.77M | 43.21M | 46.41M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.99M | -14.02M | -13.14M | -12.68M | -12.19M |
| Issuance of Common Stock | 63.47M | 6.37M | 14.95M | 15.01M | 13.42M |
| Repurchase of Common Stock | -110.73M | -102.81M | -107.92M | -129.60M | -120.73M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -61.25M | -110.46M | -106.11M | -127.27M | -119.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 126.83M | -25.42M | -3.22M | 36.05M | 19.60M |